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Abstract
             Autonomic nervous system plays an integral role in homeostasis. Autonomic modulation can 
frequently be altered in patients with cardiac disorders as well as in patients with other critical illnesses or 
injuries. Assessment of heart rate variability is based on analysis of consecutive normal R-R intervals and may 
provide quantitative information on the modulation of cardiac vagal and sympathetic nerve input. The 
hypothesis that depressed heart rate variability may occur over a broad range of illness and injury, and may 
inversely correlated with disease severity and outcome has been tested in various clinical settings over the last 
decade. This article reviews recent literature concerning the potential clinical implications and limitations of 
heart   rate   variability   assessment   in   general   medicine.                                                    
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           Autonomic nervous system plays an integral role in many aspects of homeostasis, and it is affected by a 
wide variety of pathophysiologic conditions. Assessment of heart rate variability (HRV) is based on the 
analysis of consecutive sinus rhythm R-R intervals and may provide quantitative information about the 
modulation of cardiac vagal and sympathetic nerve activities. HRV measurements can be derived from short-
term (2 to 5 minutes) or long-term ECG recordings (24 to 48 hours). It can be quantified in a number of ways 
but techniques of conventional time domain (statistical and geometrical) and frequency domain measurements 
(power spectral density) remain predominantly utilised 1. Recently, analysis of heart rate dynamics by methods 
based on non-linear system theory has been introduced, which may be an alternative way for studying the 
abnormalities in heart rate behaviour and for identifying patients with an increased cardiac mortality  2,3. 
Although HRV has been used as a non-invasive marker of the activity of the autonomic nervous system for 
over two decades, the necessary guidelines have only been established rather recently making comparison 
feasible   between   various   studies1.                                                    
           Autonomic nervous system plays a central role in the maintenance of hemodynamic stability. Cardiac 
autonomic dysfunction may result in serious complications, such as malignant cardiac arrhythmias and/or 
sudden cardiac death. The analysis of HRV has been widely explored in cardiac research during last decades. 
HRV has been recognised as a powerful risk stratifier for adverse cardiac events in patients surviving 
myocardial infarction and for identifying patients with diabetic neuropathy. HRV is affected by a number of 
physiological and pathological conditions. Significantly altered HRV can be found not only in cardiac diseases 
but also in a wide variety of pathophysiologic disorders characterised by neurohumoral activation  4.
Physiologic systems constantly change over time and respond to stimuli. Physiologic systems of young healthy 
subjects exhibit marked physiological signal variability and complexity, while aging or diseased systems show 
a loss of variability, decreased complexity, and increased regularity 5. The loss or decreased variability in the 
beat-to-beat intervals has been found in various pathophysiologic disorders 4-9. It has been hypothesised that 
decreased variability of heart rate dynamics may occur over a broad range of critical illness and injury, and 
may be inversely correlated with disease severity and outcome in both adult and paediatric patients. These 
hypotheses have been tested in last decade and have continuously been evaluated in the areas of both cardiac 
and   general   medicine.                                                                
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Clinical   application   of   HRV   analysis                                                                      
             Autonomic dysfunction is frequently seen in cardiac disorders or other diseases including those 
requiring admission to intensive care unit such as myocardial infarction  7,8, multiple organ dysfunction 
syndrome, sepsis 10, and severe head and brain injuries 11. Early studies have clearly showed that HRV is 
significantly depressed and associated with prognosis in post myocardial infarction patients 1. Recently, there 
have been reports suggesting that HRV is significantly altered in patients with critical illness, and associated 
with severity of illness and outcome in patients with head injury or brain death 6,12-18. The phenomenon of 
decomplexification of physiologic dynamics measured by HRV may also have important clinical implications 
in   other   critically   ill   patients  16,19-21.                                                                                
Cardiovascular   risk   stratification                                                                                          
Myocardial infarction and angina pectoris                                                                                                     
            A general consensus of a practical use of HRV has been reached in the setting of myocardial infarction. 
Depressed HRV indicates increased risk of malignant arrhythmias and of mortality after acute myocardial 
infarction and the prognostic value of time and geometric parameters of HRV has been consistently confirmed 
1. Carney et al showed by analysis of covariance that HRV index, with the exception of the high-frequency 
components, remains significantly lower in patients with a recent myocardial infarction and depression 
compared to those without depression. This finding may suggest a mechanism linking depression to increased 
cardiac mortality in post infarction patients 7. More recently, a prospective multicentre study showed that 1, a 
fractal HRV parameters, was the most significant independent HRV index which predicted subsequent 
mortality in a multivariate analysis after adjustments for clinical variables and left ventricular ejection fraction 
(relative risk 3.90, 95% CI 2.03 to 7.49, p <0.001) based on 697 survivors of acute myocardial infarction 9. 
Forslund et al. reported that in patients with stable angina pectoris, low HRV predicted cardiovascular death 
but not non-fatal myocardial infarction  22.                                                                                                 
Congestive heart failure                                                                                                                       
             A number of recent studies confirmed that HRV was significantly depressed in patients with 
decompensated heart failure and assessment of HRV could be used to identify heart failure patients with poor 
prognosis 8,23-25. Boveda et al examined the time domain analysis of HRV in 190 patients with heart failure 
and found that depressed HRV was of independent prognostic value 23. A multicentre trial (n=1071) ATRAMI 
demonstrated that HRV, along with baroreflex sensitivity, contributed importantly and additionally to risk 
stratification in post-infarction patients and with left ventricular ejection fraction <35%  8. Carvedilol, 
spironolactone and beta-blockers therapy reduced heart rate and improved HRV in congestive heart failure 26-
29. These effects may be attributed to the improvement of autonomic dysfunction 27. Differently, Makikallio et 
al found that HRV indexes, including the standard deviation of RR intervals, HRV index, frequency-domain 
indexes, and the short-term fractal scaling exponent of RR  intervals, failed to provide independent prognostic 
information in patients with the most severe functional impairment 30. More recently, Bilchick et al. reported 
that patients with SDNN <65.3 ms had a significantly increased risk of sudden death (p = 0.016). They showed 
that HRV was the sole independent predictor of overall mortality and was significantly associated with sudden 
death  in  patients   with   ischaemic   cardiomyopathy  24.                                                                
Malignant arrhythmias and sudden cardiac death                                                                       
             More recent report from ATRAMI confirmed the predictive value of HRV for life-threatening 
arrhythmias in patients after myocardial infarction  8. HRV (SDNN, SDANN) was also found to be 
significantly reduced in sudden death survivors of various aetiology 31. Schmitt et al 32 performed a two-step 
risk stratification to identify patients who were at high risk of ventricular arrhythmias after acute myocardial 
infarction, and used HRV as one of the non-invasive screening tests in 1,436 consecutive post-infarction 
patients. A subgroup of 248 patients was identified at high-risk and scheduled for programmed ventricular 
stimulation. During a mean of 607 day follow-up, cardiac mortality was significantly higher in the subgroup of 
96 high-risk patients who declined electrophysiological study (log-rank chi-square 9.38, p = 0.0022, relative 
risk 4.7, 1.6 to 13.9) compared to the high-risk group of patients (n=98) in whom a subsequent ICD 
implantation was guided by electrophysiological testing  32. In patients with implantable cardioverter-
defibrillators, Perkiomaki et al found that non-linear measure of HRV (scaling exponent 1) obtained from 
short-term ECG recordings yielded important prognostic information about the risk of appropriate ICD shocks 
and/or   death  33.                                                      
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Essential   hypertension                                                                                
            It has been hypothesised that in essential hypertension, an increased sympathetic and reduced vagal 
cardiac drive is coupled with an enhancement of vasomotor sympathetic modulation 34. Essential hypertension 
was associated with impaired cardiac autonomic function 35,36. In a recent study, Mussalo et al showed that the 
severity of essential hypertension was related to the severity of impairment of cardiac autonomic control 
measured by time and frequency domain analysis of HRV 37.                                               
Cardiovascular   surgery                                                                                
            Both conventional and novel (non-linear) analysis of HRV have been applied to evaluate autonomic 
modulation and cardiovascular function in patients after cardiovascular surgery 38-40. Stein et al 40 examined 
the value of HRV measurements in predicting clinical course in 106 patients undergoing abdominal aortic 
surgery. 24-hour Holter recordings taken on postoperative day 1 were analysed for standard time and 
frequency domain indices as well as non-linear slope of HRV. Decreased HRV along with increased age and 
insulin-dependent diabetes were shown to be independent predictors of prolonged hospitalisation (>7 days) 
after the operation. Their findings suggest the potential use of HRV for the prediction of postsurgical resource 
utilisation. HRV analysis was also applied to the assessment of the neural circulatory control after cardiac 
transplantation 39. Altered HRV was associated with myocardial ischaemic episodes in patients after CABG 
41. Few data exist regarding the value of preoperative HRV analysis for risk assessment before vascular 
surgery  42.                                                                                    
Assessment   of   risk   in   neurologic   disorders                                                                        
Severe   head   injury   and   brain   death                                                                              
            About two decades ago, Lowensohn tested whether or not the characteristics of the adult heart rate 
reflected the condition of the central nervous system as they appear to characterise it in the fetus. They found 
that the normal cyclic changes in heart rate were reduced in the presence of severe brain damage. HRV 
decreased rapidly when intracranial pressure rose, and   the   rate   of return of variability reflected the 
subsequent state of neuronal function, even when intracranial pressure was restored to normal. Thus, it appears 
in this limited setting that HRV may reflect the functional state of the central nervous system 17. Power 
spectral analysis of HRV was later proposed as a tool to diagnose and monitor brain damage 11,14. In 1990s 
Goldstein et al demonstrated a strong negative correlation between HRV (low frequency power) and severity 
of brain injury, survival, and neurologic outcome in paediatric populations 14-16. More recently, Conci et al 
evaluated spontaneous variability of heart rate estimated by pulse interval in 11 patients shortly before and 1 
hour after the onset of brain death. Significant spectral changes occurred after brain death with a general power 
reduction in pulse interval spectra; A significant shift of pulse interval powers toward the lower frequencies 
occurred after brain death together with a general power reduction in pulse interval spectra parameters 
describing spontaneous HRV underwent marked changes with the onset of brain death. Most likely, the 
changes reflect the cessation of activity of the cardiovascular brain stem centres. Hence, Conci et al suggested 
that spectral analysis of HRV, along with the analysis of baroreflex sensitivity and blood pressure variability, 
may be used as a complementary tool to confirm the diagnosis of brain stem death  13. Rapenne et al 
prospectively investigated whether HRV analysis could predict outcome in patients with severe head injury 
(n=20). They compared HRV (on Day 1) in patients who progressed to brain death to HRV in survivors; as 
well as HRV in survivors with good recovery (Glasgow Coma Scale >or= 10) to HRV in those with worsened 
neurologic state (Glasgow Coma Scale < 10). At day 1, in the 6 patients who had progressed to brain death, 
global HRV and parasympathetic tone were significantly higher, while during the awaking period, global HRV 
and the parasympathetic tone were significantly lower in the worsened neurologic state group. These findings 
suggest that HRV may be a helpful predictor of imminent brain death and a useful adjunct for predicting the 
outcome of patients with severe head injury 43. Baillard et al 6 further evaluated HRV continuously during the 
time of brain death. They showed that an improved method of HRV analysis immediately identified the loss in 
the spectral power of heart rate occurring during transition to brain death. This approach may be used to 
confirm the cessation of brainstem function in clinical practice.                                                                         
Acute   brainstem   stroke                                                                              
            Meglic et al assessed HRV by power spectra analysis in 14 patients with acute brainstem stroke. 
Transient dysfunction of autonomic nervous system was found in patients with acute medullary stroke (n=6) in 
contrast to those with non-medullary (n=8) brainstem stroke 44. However, the size of the study population may 
limit   the   value   of   this   report.                                                                
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Guillain-Barre   syndrome                                                                                          
            Flachenecker et al conducted serial studies in patients with Guillain-Barre syndrome and found that the 
sympathovagal balance shifted to sympathetic predominance at the height of the disease 45-47. The authors 
concluded that the 24-hour heart rate power spectrum may yield sensitive and specific markers for assessing 
the risk of impending and potentially life-threatening arrhythmias in patients with Guillain-Barre syndrome. 
Risk   assessment   in   renal   failure                                                                              
            Cardiac autonomic dysfunction is associated with mortality in patients with end-stage renal disease. 
Cashion et al evaluated the value of HRV analysis in 278 patients with end-stage renal disease to identify those 
at high risk of sudden cardiac death. They showed that end-stage renal disease patients, particularly diabetics, 
had a compromised autonomic function. Although they suggest that 24-hour time domain measure of the HRV 
held the promise of identifying patients at increased risk of death, this study contained only 5 patients with 
sudden cardiac death  48. In patients with end-stage renal disease who underwent chronic haemodialysis, 
uraemia causes similar but reversible changes in HRV in non-diabetic haemodialysis patients 49.
Evaluation   outcomes   in   sepsis   and   shock                                                                    
            Godin et al prospectively studied the relation between human endotoxemia to loss of the physiologic 
beat-to-beat variability of heart rate. They found that endotoxin administration was associated with loss of the 
variability by all measures of HRV in healthy volunteers 50. Later findings obtained from patients were in 
agreement with the experimental results from healthy subjects. Korach et al found that sepsis was strongly 
associated with a low to high frequency ration <1.50, with an odds ratio of 3.63 (95% confidence interval 1.47 
- 9.01, p=0.005) in a study of 41 patients. The authors suggested that a low to high frequency ratio <1.0 may 
be a diagnostic test for sepsis 10. However, the reproducibility of the low to high frequency ratio is a reason for 
concern   and   these   findings   need   to   be   confirmed   by   studying   larger   populations.
            It was hypothesised that septic shock resulted in an uncoupling of organ system interconnectivity and 
that the uncoupling phenomenon could be quantified as a loss in HRV  51. Goldstein et al showed that 
endotoxin caused a loss in HRV in rabbit models of sepsis. They speculated that a concomitant decrease in 
low-frequency HR power as mean arterial pressure decreases may be an early marker for impending shock 52. 
Ellenby et al evaluated uncoupling and recoupling phenomenon in 7 children with septic shock by observing 
serial changes in HRV. Heart rate time series were analysed at 6-hour intervals of during hospitalisation at 
paediatric intensive care unit. Six of 7 patients showed an increase over time in low-frequency component of 
HRV and the low to high-frequency ratio, whereas high-frequency component of HRV decreased. The study 
also compared the change in mean heart rate, heart rate standard deviation, and power spectral HRV values 
during the first 24-hour of paediatric intensive care unit hospitalisation versus the remainder of the stay. In the 
later hospitalisation, low-frequency component of HRV and the low-/high-frequency ratio increased, whereas 
high-frequency component of HRV decreased over the course of the illness. This report showed the potential 
value of monitoring HRV in paediatric patients with septic shock51. These results were in agreement with 
early studies showing evidence of decomplexification in experimental models of sepsis52 and with recent 
clinical   studies10,53.                                                                  
Fetal   and   neonatal   monitoring                                                                          
            As early as in 1965, Hon and Lee noted that fetal distress was preceded by alterations in the beat-to-
beat intervals before any appreciable changes occurred in heart rate itself 54. More recently, Griffin et al 
prospectively evaluated the heart rate characteristics, which described the symmetry of histogram of RR 
intervals, in 89 infants at risk for sepsis and sepsis-like illness. They found that new-born infants who had 
abrupt clinical deterioration as a result of sepsis and sepsis-like illness, had abnormal heart rate characteristics. 
Heart rate characteristics and the Score for Neonatal Acute Physiology worsened over 24 hours before the 
clinical suspicion of sepsis. Their findings suggested that HRV analysis might help with an earlier diagnosis 
and more effective therapy 55. Chung et al performed a fetal HRV analysis in 76 pregnant women. They 
reported that a computerised spectral analysis of fetal HRV was a good predictor of fetal distress by showing a 
negative predictive accuracy for predicting presumed distress or acidemic distress of 99%. However, the 
positive predictive accuracy was only 12%  56. The effect of maternal administration of meperidine with 
promethazine should be taken into account when monitoring fetal HRV during the active phase of normal 
labour  57.                                                                                      
Other   clinical   potential                                                                                                
            A number of recent studies showed that altered HRV was found in other patients populations including
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Parkinson disease 58, sleep apnoea 59,60, Chagas' disease 61 etc. Altered HRV was also associated with some 
critical conditions such as patients with cirrhosis of the liver  62, pregnant eclampsia  63, and tetanus  64. 
However, the clinical use of HRV assessment in these areas has not been systematically explored. 
Future   prospects                                                                                  
            The expansion of heart rate variability analysis has been facilitated by the remarkable development of 
computer sciences and digital signal processing during the last decades. The prognostic value of time and 
geometric parameters of HRV has been consistently confirmed. It seems encouraging that HRV analysis may 
provide additional diagnostic and prognostic information within the context of multiple confounding factors, 
which are associated with various pathophysiologic conditions. It has been known that both linear and non-
linear components of HRV may be significantly altered in critically ill patients 65. The newer non-linear 
methods might predict risk more precisely in cardiac or other critically ill patients2,9,66, however, further 
evaluations are needed. This non-invasive methodology is of substantial utility to evaluate autonomic control 
mechanisms and to identify patients with an increased mortality in spite of an incomplete understanding of the 
physiological significance of HRV parameters. Further prospective studies are required to define limits of 
HRV indices for the use in managing individual patient under various clinical settings.                                    
Conclusions
            HRV analysis is a recognised tool for the estimation of cardiac autonomic modulations. Reduced HRV 
is a powerful and independent predictor of an adverse prognosis in patients with cardiac disease. It has a 
potential to become a non-invasive diagnostic and prognostic index in clinical practice, particularly in patients 
with post myocardial infarction and diabetic neuropathy. Although assessment of HRV in other clinical 
settings seems to be helpful and promising, substantial number of further prospective studies in larger 
population are needed to evaluate the validity of HRV in general medicine.                                     
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